Cargando…
Antibiotic Therapy Using Phage Depolymerases: Robustness Across a Range of Conditions
Phage-derived depolymerases directed against bacterial capsules are showing therapeutic promise in various animal models of infection. However, individual animal model studies are often constrained by use of highly specific protocols, such that results may not generalize to even slight modifications...
Autores principales: | Lin, Han, Paff, Matthew L., Molineux, Ian J., Bull, James J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6266388/ https://www.ncbi.nlm.nih.gov/pubmed/30424521 http://dx.doi.org/10.3390/v10110622 |
Ejemplares similares
-
Therapeutic Application of Phage Capsule Depolymerases against K1, K5, and K30 Capsulated E. coli in Mice
por: Lin, Han, et al.
Publicado: (2017) -
Experimental evolution of UV resistance in a phage
por: Tom, Eric F., et al.
Publicado: (2018) -
Synergy as a rationale for phage therapy using phage cocktails
por: Schmerer, Matthew, et al.
Publicado: (2014) -
Promises and Pitfalls of In Vivo Evolution to Improve Phage Therapy
por: Bull, James J., et al.
Publicado: (2019) -
Diversity and Function of Phage Encoded Depolymerases
por: Knecht, Leandra E., et al.
Publicado: (2020)